Adirondack Trust CO Novo Cure LTD Transaction History
Adirondack Trust CO
- $259 Million
- Q4 2024
A detailed history of Adirondack Trust CO transactions in Novo Cure LTD stock. As of the latest transaction made, Adirondack Trust CO holds 100 shares of NVCR stock, worth $2,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$2,100
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$255 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$248 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$186 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$101 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$57.5 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.2B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...